These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 32085732)

  • 41. Infective Endocarditis Caused by Staphylococcus aureus After Transcatheter Aortic Valve Replacement.
    Del Val D; Abdel-Wahab M; Mangner N; Durand E; Ihlemann N; Urena M; Pellegrini C; Giannini F; Gasior T; Wojakowski W; Landt M; Auffret V; Sinning JM; Cheema AN; Nombela-Franco L; Chamandi C; Campelo-Parada F; Munoz-Garcia E; Herrmann HC; Testa L; Won-Keun K; Castillo JC; Alperi A; Tchetche D; Bartorelli AL; Kapadia S; Stortecky S; Amat-Santos I; Wijeysundera HC; Lisko J; Gutiérrez-Ibanes E; Serra V; Salido L; Alkhodair A; Vendramin I; Chakravarty T; Lerakis S; Vilalta V; Regueiro A; Romaguera R; Kappert U; Barbanti M; Masson JB; Maes F; Fiorina C; Miceli A; Kodali S; Ribeiro HB; Mangione JA; Sandoli de Brito F; Actis Dato GM; Rosato F; Ferreira MC; Corriea de Lima V; Colafranceschi AS; Abizaid A; Marino MA; Esteves V; Andrea J; Godinho RR; Alfonso F; Eltchaninoff H; Søndergaard L; Himbert D; Husser O; Latib A; Le Breton H; Servoz C; Pascual I; Siddiqui S; Olivares P; Hernandez-Antolin R; Webb JG; Sponga S; Makkar R; Kini AS; Boukhris M; Gervais P; Linke A; Crusius L; Holzhey D; Rodés-Cabau J
    Can J Cardiol; 2022 Jan; 38(1):102-112. PubMed ID: 34688853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced vancomycin susceptibility in an in vitro catheter-related biofilm model correlates with poor therapeutic outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Abdelhady W; Bayer AS; Seidl K; Nast CC; Kiedrowski MR; Horswill AR; Yeaman MR; Xiong YQ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1447-54. PubMed ID: 23295925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antistaphylococcal penicillins vs. cefazolin in the treatment of methicillin-susceptible Staphylococcus aureus infective endocarditis: a quasi-experimental monocentre study.
    Lefèvre B; Hoen B; Goehringer F; Sime WN; Aissa N; Alauzet C; Jeanmaire E; Hénard S; Filippetti L; Selton-Suty C; Agrinier N;
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2605-2616. PubMed ID: 34383175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.
    Chi CY; Lauderdale TL; Wang SM; Wu JM; Yang YJ; Liu CC
    J Clin Microbiol; 2008 Feb; 46(2):810-3. PubMed ID: 18077634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study.
    Fernández-Hidalgo N; Ribera A; Larrosa MN; Viedma E; Origüen J; de Alarcón A; Fariñas MC; Sáez C; Peña C; Múñez E; García López MV; Gavaldà J; Pérez-Montarelo D; Chaves F; Almirante B
    Clin Microbiol Infect; 2018 Sep; 24(9):985-991. PubMed ID: 29269091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiresistant-MRSA tricuspid valve infective endocarditis with ancient osteomyelitis locus.
    Chesi G; Colli A; Mestres CA; Gambarati G; Boni F; Gherli T
    BMC Infect Dis; 2006 Jul; 6():124. PubMed ID: 16872491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.
    Joo EJ; Park DA; Kang CI; Chung DR; Song JH; Lee SM; Peck KR
    Korean J Intern Med; 2019 Nov; 34(6):1347-1362. PubMed ID: 29347812
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremia.
    Abraham J; Mansour C; Veledar E; Khan B; Lerakis S
    Am Heart J; 2004 Mar; 147(3):536-9. PubMed ID: 14999206
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.
    Dortet L; Anguel N; Fortineau N; Richard C; Nordmann P
    Int J Infect Dis; 2013 Nov; 17(11):e1076-7. PubMed ID: 23578850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
    Adhikari RP; Shrestha S; Barakoti A; Amatya R
    BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance.
    Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL
    Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
    Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
    JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    Rasigade JP; Leclère A; Alla F; Tessier A; Bes M; Lechiche C; Vernet-Garnier V; Laouénan C; Vandenesch F; Leport C;
    Front Cell Infect Microbiol; 2018; 8():187. PubMed ID: 29938201
    [No Abstract]   [Full Text] [Related]  

  • 54. Infective endocarditis in maintenance hemodialysis patients: fifteen years' experience in one medical center.
    Chang CF; Kuo BI; Chen TL; Yang WC; Lee SD; Lin CC
    J Nephrol; 2004; 17(2):228-35. PubMed ID: 15293522
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nasopharyngeal carriage, spa types and antibiotic susceptibility profiles of Staphylococcus aureus from healthy children less than 5 years in Eastern Uganda.
    Kateete DP; Asiimwe BB; Mayanja R; Mujuni B; Bwanga F; Najjuka CF; Källander K; Rutebemberwa E
    BMC Infect Dis; 2019 Dec; 19(1):1023. PubMed ID: 31791276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis.
    Brown J; Brown KA; Forrest A
    Clin Ther; 2011 Oct; 33(10):1475-82. PubMed ID: 21925733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methicillin resistance and risk factors for embolism in Staphylococcus aureus infective endocarditis.
    Hsu RB; Lin FY
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):860-6. PubMed ID: 17564990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical and epidemiological factors associated with methicillin resistance in community-onset invasive Staphylococcus aureus infections: prospective multicenter cross-sectional study in Korea.
    Kim ES; Kim HB; Kim G; Kim KH; Park KH; Lee S; Choi YH; Yi J; Kim CJ; Song KH; Choe PG; Kim NJ; Lee YS; Oh MD;
    PLoS One; 2014; 9(12):e114127. PubMed ID: 25485895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
    Coombs GW; Daley DA; Lee YT; Pang S
    Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
    Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC
    Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.